The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959

Pharmacology Biochemistry and Behavior

Volumn 80, Issue 4, 2005, Pages 597-601

  Zhen, Xuechu ^a   Goswami, Satindra ^a   Friedman, Eitan ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

6 hydroxydopamine (6 OHDA); Dopamine receptor; Inositol 1,4,5 triphosphate (IP3); Parkinson's disease (PD); Phosphatidylinositol

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; MESULERGINE; OXIDOPAMINE; PHOSPHATIDYLINOSITOL; PRAZOSIN; SEROTONIN ANTAGONIST; SPIPERONE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT; APOMORPHINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; PHOSPHOLIPASE C; SK&F 83959;

ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; MALE; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REGULATORY MECHANISM; ANIMAL; ANIMAL BEHAVIOR; BRAIN LEVEL; CHEMICAL SYMPATHECTOMY; HIPPOCAMPUS; METABOLISM; NEOSTRIATUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STEREOTYPY;

ANIMALIA; PARKINSONIA;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HIPPOCAMPUS; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; NEOSTRIATUM; OXIDOPAMINE; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; STEREOTYPED BEHAVIOR; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 22444436669     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.016     Document Type: Article

References (20)

1. 1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 1999a;364:33-41.
2. 1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology 1999b;146:328-34.
3. Betarbe TR, Sherer TB, Greenamyre JT. Animal models of Parkinson's disease. BioEssays 2002;24:308-18.
4. 2 dopamine receptor stimulation in unilateral 6-hydroxy-dopamine-lesioned rats. J Neurosci 2002;20:1849-57.
5. 1-like" dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 1995;116:2120-6.
6. Felder CC, Jose PA, Axelrod J. The dopamine-1 agonist, SKF82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 1989;248:171-5.
7. 1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. Mol Pharmacol 1993;44:1113-8.
8. 1A knockout mice. Mol Pharmacol 1997;51:6-11.
9. Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat-relationship to circling behavior. Biochem Pharmacol 1995;49:1185-93.
10. 1 dopamine receptors in rat brain. J Neurochem 2003;85:378-86 [2002].
11. Kaytor MD, Orr HT. The GSK3 beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol 2002;12:275-8.
12. Nagatsu T. Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 2002;109:731-45.
13. 1 receptors. J Neurochem 1997;69:639-44.
14. 35S] GTPγS binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology 2001;40:826-37.
15. Schwarting RKW, Huston JP. The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996;50:275-331.
16. Undie AS, Friedman E. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics. Psychopharmacology 1988;96:311-6.
17. 1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 1990;253:987-92.
18. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 1994;62:2045-8.
19. 1A receptor regulation of phospholipase C isoform. J Biol Chem 1996;271: 19503-8.
20. 2 dopamine receptor-mediated behavioral supersensitivity in 6-OHDA-lesioned Parkinson's model. Mol Pharmacol 2002;62:1356-63.